Filing Flows › InspireMD (NSPR) › Q1 2026
InspireMD (NSPR) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 7, 2026
InspireMD (NSPR) reported revenue of $3.4M for the first quarter 2026 (Q1 2026), +122% from a year earlier and +8% from the quarter before. Operating margin was -411.4%, net loss $13.7M (402.9% of revenue).
InspireMD, Q1 2026: revenue $3.4M (+122% year over year), operating margin -411.4%, net loss $13.7M, operating cash flow −$12.3M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.4M | +8% | +122% |
| Operating profit | −$14.0M | — | — |
| Net earnings | −$13.7M | — | — |
| Operating cash flow | −$12.3M | — | — |
What changed
Revenue was $3.4M in Q1 2026, up 122% year over year and up 8% from the previous quarter.
Gross margin was 20.2%, up 1.1 points from Q1 2025. Operating costs exceeded revenue by $14.0M, an operating margin of -411.4%. Operating expenses grew 25% against revenue growth of 122%. The fastest-growing cost line was Sales & marketing (+88%). The quarter ended with a net loss of $13.7M, wider than the previous quarter's $11.8M loss.
Operating cash flow was −$12.3M. Non-cash charges added back $149K of depreciation and $2.1M of share-based compensation. Working capital and other items used $902K. Capital expenditures of $194K exceeded it, leaving free cash flow of −$12.5M.
Questions
What was InspireMD's revenue in the first quarter 2026?
InspireMD (NSPR) reported revenue of $3.4M for the first quarter 2026 (Q1 2026), +122% from a year earlier and +8% from the quarter before.
Was InspireMD profitable in the first quarter 2026?
Operating loss was $14.0M (-411.4% of revenue) and net loss $13.7M.
Source: InspireMD 10-Q on SEC EDGAR.